OpenVSafe by OpenVAERS
Search V-safe

Y23-15422-07760

3 vaccinations 5 coded responses 22 check-ins 5 free-text entries 2 call cases
Sex
Female
Age at first dose
41-45
ZIP prefix
197 / DE
Registered
2020-12-23
Relationship
Self
Race
Black or African American
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-23
    Registered in v-safe
  2. 2020-12-23
    Dose 1 — Moderna
  3. 2021-01-15
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  4. 2021-01-20
    Dose 2 — Moderna
  5. 2021-01-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  6. 2021-01-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to work
    Adult check-in
  7. 2021-01-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Redness, Swelling · Fatigue or tiredness
    Adult check-in
  8. 2021-01-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fatigue or tiredness
    Adult check-in
  9. 2021-01-25
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Redness, Swelling, Itching · None
    Adult check-in
  10. 2021-01-26
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Redness, Itching · None
    Adult check-in
  11. 2021-01-27
    Health check-in — day 7, dose 2
    Feeling: Good · Site: Redness · Fatigue or tiredness
    Adult check-in
  12. 2021-02-03
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-02-11
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-02-17
    Health check-in — day 28, dose 2
    Feeling: Fair
    Adult check-in
  15. 2021-03-03
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-04-21
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-07-21
    Survey response — 6 months, dose 2
    MedDRA: Ageusia, Anosmia, Cough, Pyrexia, Respiratory tract infection, SARS-CoV-2 test negative, Sinusitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Respiratory infection, sinusitis, loss of smell or taste, fever, coughing. Tested negative for Covid-19 twice. Lasted 10 days.
    MedDRA releases: 2024-11 · check-in free text available
  18. 2021-07-21
    Report sent to call center — 6 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  19. 2021-07-27
  20. 2021-07-30
    Call successful
    Participant prefers to complete VAERS report online
  21. 2022-01-20
    Survey response — 12 months, dose 2
    MedDRA: Headache, Oropharyngeal pain, Pain, Pyrexia, SARS-CoV-2 test negative, SARS-CoV-2 test positive, Sinus pain, Upper respiratory tract congestion, Vomiting — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Week of Dec 27- Had a week of fever, vomiting, sinus and body ache but tested negative for covid Currently covid positive with fever,upper respiratory congestion, sore throat bodyache, headache
    MedDRA releases: 2024-11 · check-in free text available
  22. 2022-01-20
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  23. 2022-01-21
  24. 2022-04-01
    Dose 3 — Moderna
  25. 2022-04-26
    Health check-in — day 21, dose 3
    Feeling: Fair
    Adult check-in
  26. 2022-05-01
    Health check-in — day 28, dose 3
    Feeling: Fair
    Adult check-in
  27. 2022-05-06
    Survey response — day 35, dose 3
    MedDRA: Dyspnoea — Feeling: Good
    Free text: Some shortness of breath.
    MedDRA releases: 2024-11 · check-in free text available
  28. 2022-05-13
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  29. 2022-07-01
    Survey response — 3 months, dose 3
    MedDRA: Menstrual disorder, Menstruation irregular — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Increased irregularities and intensity in menstrual cycle
    MedDRA releases: 2024-11 · check-in free text available
  30. 2022-10-02
    Survey response — 6 months, dose 3
    MedDRA: Fatigue, Nausea, Pyrexia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Intermittent fatigue, fever, nausea symptoms
    MedDRA releases: 2024-11 · check-in free text available
  31. 2023-04-01
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-23Moderna
22021-01-20Moderna
32022-04-01Moderna No

Call center

ReportedOutcomeVAERS-related outcome
2021-07-21 Successful
2021-07-30
Participant prefers to complete VAERS report online
2022-01-20 Unsuccessful

Free text

Release 9 — 6 months, dose 2

2021-07-21

Symptoms: Respiratory infection, sinusitis, loss of smell or taste, fever, coughing. Tested negative for Covid-19 twice. Lasted 10 days.

Release 10 — 12 months, dose 2

2022-01-20

Symptoms: Week of Dec 27- Had a week of fever, vomiting, sinus and body ache but tested negative for covid Currently covid positive with fever,upper respiratory congestion, sore throat bodyache, headache

Release 11 — day 35, dose 3

2022-05-06

Symptoms: Some shortness of breath.

Release 12 — 3 months, dose 3

2022-07-01

Symptoms: Increased irregularities and intensity in menstrual cycle

Release 12 — 6 months, dose 3

2022-10-02

Symptoms: Intermittent fatigue, fever, nausea symptoms

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAgeusia · · ✓
SDAnosmia · · ✓
SDCough · · ✓
SDDyspnoea · · ✓
SDFatigue · · ✓
SDHeadache · · ✓
SDMenstrual disorder · · ✓
SDMenstruation irregular · · ✓
SDNausea · · ✓
SDOropharyngeal pain · · ✓
SDPain · · ✓
SDPyrexia · · ✓
SDRespiratory tract infection · · ✓
SDSARS-CoV-2 test negative · · ✓
SDSARS-CoV-2 test positive · · ✓
SDSinus pain · · ✓
SDSinusitis · · ✓
SDUpper respiratory tract congestion · · ✓
SDVomiting · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release